The meeting will also review data for the vaccine candidate by Pfizer, which too applied for emergency approval but sought more time when the last meeting was held on December 9.
source https://www.hindustantimes.com/india-news/serum-institute-submits-more-data-for-emergency-use-licence/story-b4at1OnzLo3RVzHmT76NkK.html
No comments:
Post a Comment